chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in or under the skull; Body-ache; restlessness; Fatigue; Injection site Pain; Pain in the right arm; Sporadic random bursts of pain in the head; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 10Mar2021 08:15 (Lot number: EN6208) at the age of 54 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "High Cholesterol" (unspecified if ongoing); "Overweight" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL taken for hypertension (ongoing); SIMVASTATIN taken for hypertension (ongoing); AMLODIPINE taken for hypertension (ongoing). Vaccination history included: Bnt162b2 (Product=COVID-19, brand=Pfizer, lot unknown=False, Batch/Lot number: EL9266, administration date=17Feb2021,, administration time=08:15 , vaccine location=Right arm,, dose number=1), administration date: 17Feb2021, when the patient was 54 years old, for Covid-19 Immunisation, reaction(s): "Injection site pain", "Body Ache", "Tiredness/Exhaustion feeling", "restlessness", "Headache". The following information was reported: FATIGUE (non-serious) with onset 11Mar2021, outcome "recovering", described as "Fatigue"; VACCINATION SITE PAIN (non-serious) with onset 11Mar2021, outcome "recovering", described as "Injection site Pain"; PAIN IN EXTREMITY (non-serious) with onset 11Mar2021, outcome "recovering", described as "Pain in the right arm"; HEADACHE (non-serious) with onset 11Mar2021, outcome "recovering", described as "Sporadic random bursts of pain in the head"; PAIN (non-serious), outcome "not recovered", described as "Pain in or under the skull"; PAIN (non-serious), outcome "unknown", described as "Body-ache"; RESTLESSNESS (non-serious), outcome "unknown", described as "restlessness". Therapeutic measures were not taken as a result of fatigue, vaccination site pain, pain in extremity, headache, pain, pain, restlessness.  Additional information: Facility type vaccine: Public Health Clinic facility. The patient did not receive any other vaccine within four weeks of vaccination. The patient had not Covid prior vaccination and not Covid tested post vaccination. Known allergies: No.  No follow-up attempts are possible. No further information is expected.
Blood clot; He was peeing a lot of blood; all of the joints went wondering in one another that was swelling up and it just so painful. Rheumatoid Arthritis layered up; leg swells up twice the size of the other leg; This is a spontaneous report from a contactable consumer reporting for his father.     A male patient of an unspecified age received BNT162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for Covid-19 immunisation.  Medical history included rheumatoid arthritis. The patient's concomitant medications were not reported. The patient experienced blood clot on an unspecified date with outcome of unknown, he was peeing a lot of blood  on an unspecified date with outcome of unknown, all of the joints went wondering in one another that was swelling up and it just so painful/ he is just swelling up, leg swells up twice the size of the other leg on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included ultrasound scan: clot blood. The event thrombosis and hematuria were considered Important Medical Events.  Course of the events: Reporter stated, "My father got the Pfizer Covid vaccine  couple of weeks ago and it caused I think Rheumatoid Arthritis layered up in his joints one of the times started swelling up. He got a blood clot, his legs swelled up like twice the size of the other leg and they did ultrasound on it and got a blood clot. They put him up on blood thinners (Unspecified Medication) now today he had an appointment with the doctor in the room and when he was there he went to the bathroom and then he was peeing a lot of blood. Doctor told him that It should be okay if stop taking the blood thinners and she cleared up and that's it and I am like freaking out that why would they not got him to the hospital. He went to the hospital because it's the other blood clot. People saying this is on the blood thinner. I don't know why is they rolling up a lot. Nobody wants to say its from the vaccine but it is happen in half an hour within the vaccine, its started."  Information about Lot number has been requested.
after the first does they have an increase in their Tinnitus; first dose of the Moderna covid19 vaccine 8 months ago, and never getting the second; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (after the first does they have an increase in their Tinnitus) and PRODUCT DOSE OMISSION ISSUE (first dose of the Moderna covid19 vaccine 8 months ago, and never getting the second) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (after the first does they have an increase in their Tinnitus) and PRODUCT DOSE OMISSION ISSUE (first dose of the Moderna covid19 vaccine 8 months ago, and never getting the second). At the time of the report, TINNITUS (after the first does they have an increase in their Tinnitus) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (first dose of the Moderna covid19 vaccine 8 months ago, and never getting the second) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication use was reported.
Flu-like Symptoms; aching; dizziness; nauseous; feeling hot; Shivering; muscle pain; joint pain; This case was reported by a nurse via call center representative and described the occurrence of influenza-like symptoms in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd March 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In March 2019, less than a week after receiving Shingrix, the patient experienced influenza-like symptoms, pain, dizziness, nausea, feeling hot, shivering, muscle pain and joint pain. In March 2019, the outcome of the influenza-like symptoms, pain, dizziness, nausea, feeling hot, shivering, muscle pain and joint pain were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, pain, dizziness, nausea, feeling hot, shivering, muscle pain and joint pain to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient who herself was nurse. The patient  received a dose on left arm and experienced flu-like symptoms described as aching, dizziness, nauseous, feeling hot, shivering, and muscle and joint pain. The symptoms lasted about 3 days after the first dose. The reporter did not consent to follow-up. For tolerance for dose 2, refer case US2019GSK113363
- Heart Arrhythmia (Premature Ventricular Contractions, PVC) - Bradycardia - Shortness of breath - Non-specific pressure/pain under rib 8/9, increasing with external pressure or after meals.  Possible Splenomegaly  All symptoms appeared within 24 hours of vaccination.  Intensified substantially within 48 hours.  Non-specific pressure/pain subsided at 96 hours. All other symptoms remain(4+ days since vaccination at the time of writing this)
Information has been received from a pharm D that a medical assistant stated that a 71 year old male patient who on 21-NOV-2008 was vaccinated with PNEUMOVAX. On 21-NOV-2008 the patient developed "serious cellulitis" and presented with redness and swelling of upper arm along aspect extending downward elbow. Initially redness at injection site but this had resolved leaving mid and distal area of arm with local oedema. The patient had sought medical attention. The outcome of "serious cellulitis" was not reported. This is one of several reports by the same reporter. Additional information has been requested. Additional information has been requested.
Soreness at injection site fairly prolonged. June: Increase in Osteoarthritis symptoms more grumpy areas are shoulders and back. Mild irritation before the vaccine and now it's unpleasant discomfort. More frequent and increasing tendencies. I have had physical therapy. To some extent it was helpful. Ongoing exercises are helpful as far as what to avoid and what to do. It has made my kayaking and bicycling not as much better.  I have had a couple of consultations from neurologist and with a neurosurgeon. Back discomfort and sciatic nerve pain but no physical procedures done at this time. Trying to parse out to see if any symptoms have to do with the Peripheral neuropathy or not.
Patient states that after he returned home from receiving the vaccine he experienced difficulty breathing and went to the hospital. While there he was informed that he had contracted a bacterial infection and was treated for Bacterial Pneumonia.
I tested positive on 8/8/22 and started with head cold symptoms and fever up to 101.1. From the 8/9-12 I had a severe sore throat. I was very tired and exhausted. I started Paxlovid on 8/8. On the 8/11 or 12th I went to the doctor because the sore throat was really bad. Around the 9/8 I was diagnosis with bronchitis. On 9/30 I had my gallbladder out. I still have a little bit of a cough
recently diagnosed  with an "immunocompromised situation; This spontaneous case was reported by a pharmacist and describes the occurrence of IMMUNODEFICIENCY (recently diagnosed  with an "immunocompromised situation) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IMMUNODEFICIENCY (recently diagnosed  with an "immunocompromised situation). At the time of the report, IMMUNODEFICIENCY (recently diagnosed  with an "immunocompromised situation) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter.  No treatment medications was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Feb-2022: Follow-up received contain non significant information.
Patient heart rate went upto 120 beats per minute after vaccination and stayed about 100 after 20 minutes of sitting down.
Developed fever of 105F, post vax. Was very ill for 2 weeks.
Shot 1: Site soreness (severe) lasting 1 week, fever, chills, headache, tiredness 48 hours. Shot 2: Site soreness (not as bad as shot 1) for 1 week.  48 hours tiredness, headache, chills, fever.  Next 48 hours: tired, headache.  One week later starting experiencing dizziness, fatigue, tinnitus.  Continuing off and on one month after 2nd vaccine. Have a good then several bad days.  Seems to be getting worse and more chronic.  Wake up tired but not dizzy and within 45 minutes dizziness starts up and continues through until late afternoon.  Fatigue is chronic and fairly bad no matter how much sleep I get.   Tinnitus (which I have never had before) is consistent but not super severe.   Never had dizzy spells or vertigo before either.
This is a spontaneous report from a contactable healthcare professional (Physician's assistant) received via a Pfizer sales representative. A 16-year-old male patient received TRUMENBA (lot number and expiration date unknown) at a single dose and BEXSERO at an unspecified dose and frequency; both via an unspecified route of administration on Jul2018 for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Jul2018, the patient had a wrong vaccine administered. The reporter explained that in Jul2018, a meningococcal group b rlp2086 and a meningococcal vaccine b rfhbp/nada/nhba omv were both given at the same time, same visit, to the reporter's 16 year old son (the patient). He was supposed to get MENACTRA but was given meningococcal group b rlp2086 instead because they pulled the wrong one. A couple of days after these events, the patient developed a sinus infection and a double ear infection on an unspecified date in 2018. The reporter stated that nothing happened except that the patient did have the sinus infection and a double ear infection a couple of days later. The causality of the events was reported as unknown. The reporter asked when should the patient get the second dose of meningococcal vaccine b rfhbp/nada/nhba omv, and should he wait until he gets his meningococcal (Groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine. The outcome of the events was unknown. Information on the lot/batch number has been requested.
Patient returned to administering nurse shortly after vaccination with red injection site that was warm and itchy.  50 mg IM Benadryl given at site of injection.  Symptoms subsided after 30 minutes.  Patient reported to employee health in 24 hours with red arm accompanied by heat and streaking.  Diagnosis was cellulitis and clindamycin prescribed.  Patient is fully recovered.
5/7/07. 0500 CST PT AWOKE WITH NUMB L HAND AND CRAMPED TRICEP MUSCLE. TINGLING AND NUMBNESS IN HIS HAND HAVE CONTINUED THROUGHT THE DAY AND SEEM TO FLUCTUATE OR "MOVE" AREAS OF HIS HAND. CERTAIN POSITIONS OF HIS ARM AND HAND DO NOT SEEM TO HAVE ANY EFFECT, POSITVE OR NEGATIVE, ON THE TINGLING AND NUMBNESS. APPROX 1600 CST PT C/O FEELING SHARP PAIN BETWEEN HIS RING AND MIDDLE FINGER.  "IT FELT LIKE A SPIKE BEING DRIVEN BTWN MY MIDDLE AND RING FINGERS ALL THE WAY DOWN TO MY WRIST." PAIN LASTED 30-45 MIN.
Chills-3 hours straight starting at 4am, then sporadic for next 12 hours General fatigue, muscle and joint aches, lack of appetite, mild nausea, headache  over the 2 days after vaccine
on the 20th day of receiving first shot, in the afternoon I felt tired and went to bed. later got up with chest pain and a severe breathing difficulty. Lost balance twice before checking into emergency in Hospital Had heart rate of 139 and high blood pressure at the emergency. Transferred to second hospital and released on March 29, 2021 around noon.
Hospitalized with 9 days runny nose and mild cough. R sided chest pain, palpitations, possible myocarditis.
Given injection of MENACTRA on 8/5/10 started with erythema 20 hrs later peaked at 98 degrees with erythema, induration (12 X 17 cm) receded spontaneously.
Started out with the Stiffness in my left arm then the next morning my ribs started hurting (excruciating pain) and it stayed like that for 6 weeks. I went to a doctor to have it checked and he gave me a cortisone shot and he also gave me an oral medication and eventually that helped with the pain and the symptoms subsided.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On an unknown date the patient was vaccinated with M-M-R II (dose and route unknown). No concomitant medications were reported. On an unknown date the patient experienced unspecified reaction to a dose of M-M-R II. The outcome of unspecified reaction is unknown. Additional information has been requested.
"Moderna COVID-19 Vaccine EUA" Soreness/pain at injection site. Noticed 8 hours after injection. Lasted about 48 hours
IMMUNIZATIONS GIVEN SAME DAY PATIENT EXPIRED FROM SIDS. NO ADVERSE REACTION NOTED TO IMMUNIZATION.
Numbness, tingling of both hands, fingertips although worse on the right side where one of the vaccines was administered.  Also with fever to 99, myalgias beginning the day after.
her titers were negative for Rubella.; She developed the mumps.; This spontaneous report was received from a female consumer of 55-year-old referring to herself. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unspecified date in September 1966, the patient was administered with the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown). Then, on an unspecified date in 1970, she was administered with the second dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown); 1 dosage form, both administered for prophylaxis by subcutaneous route (concentrations, schedules, lot numbers, and expiration dates were not reported).   On an unspecified date in 1970, after being administered the 2nd dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown), the patient developed mumps. In December 1999, the patient had a blood work performed, which reported positive titers. Then, on an unspecified date in 2020, (reported as "a few weeks ago") she had a blood work performed, which reported her titers were negative for Rubella (rubella antibody negative). The patient did not seek medical attention.  At the time of reporting, the patient was not recovered from mumps and rubella antibody negative. The relationship between the events and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown) was not reported.
Woke up in the morning-blood dripped from nose. Hands, feet and mouth were purple. Rushed to doctor's office. They checked her sugar level up to 367. Rushed to ER. Fever up to 103.2. Became extremely ill, dehydrated , lethargic. Tested for diabetes. Developed two (2) different rashes all over body at two (2) different times, consisting of red bumps all over the body/skin. Each rash lasted about 1 week.
screaming 45min+ plus till 9Pm & inconsolable;t103 leg hot;slept little;mom gave advil then APAP, cool compress;
Headache, arm pain (where the injection occurred), nausea, rapid heart beating, anxiety.
Chills, fever, headache lasted 2-3 days. Nausea lasted 4 days. Loss of appetite 4 days.
9/19/18 @ 425PM, PATIENT CALLED WITH CONCERNS ABOUT POTENTIAL SIDE EFFECTS FROM TRAVEL VACCINES RECEIVED 7/12/18 FOR TRIP, RETURNED 8/10/18. PT STATES X 3 WEEKS, HAS HAD INTERMITTENT NIGHT FEVERS TMAX 101, IMPROVED WITH MOTRIN, AND CONSISTENT ITCHY HANDS AND FEET X 3 WEEKS, TEMPORARY RELIEF WITH BENADRYL. DENIES NVD, SORE THROAT, BLISTERS/RASHES. PATIENT DENIES ANY NEW MEDICATIONS/FOODS/CREAMS/HYGIENE PRODUCTS. PATIENT REPORTS CONSISTENT EXPOSURE TO "BLACK BUGS" AND DID HAVE SEVERAL BUG BITES DURING HER TRIP-- DENIES MOSQUITO EXPOSURE. PATIENT DID NOT TAKE ANY ANTIMALARIAL PROPHYLAXIS. ADVISED PATIENT TO FOLLOW UP WITH PCP FOR FURTHER EVALUATION ASAP OR REPORT TO ER/URGENT CARE IF S/S WORSEN, FAIL TO IMPROVE. CONCERNS FOR POTENTIAL VACCINE REACTION ADDRESSED-- WILL SEND VAERS REPORT (ATTACHED TO 7/12/18 ENCOUNTER). CONCERNS FOR POTENTIAL VECTOR-BORNE RELATED ILLNESS ADDRESSED AS WELL. PATIENT VOICED UNDERSTANDING AND AGREED WITH PLAN OF CARE/RN
rt leg pain, weakness, numbness; lt leg numbness; dx transverse myelitis;
Left upper arm swollen and 5x5cm area is red, wam and tender. Treated for cellulitis with augmentin 200mg.
Information has been received from a physician concerning a 12 year old female with no known allergies or medical history who on 07-AUG-1995 was vaccinated SC in the arm with a first dose of Varivax (lot # 608579/0407B). Concomitant vaccination included a first dose of MMR (lot # 615609/0621B) given SQ in the arm and a fourth dose of HibTiter (lot # M005LK) given IM in the thigh. There was no illness at the time of vaccination. On 10-MAR-2007 the patient developed chickenpox lesions which were reported to be papules with erythema, pustules and a few scabbed lesions on her face, chest and abdomen. It was reported that the patient had 30-40 lesions. A clinical exam was performed, no labs or diagnostic tests were performed. Subsequently, on an unspecified date the patient recovered. It was reported that there was chickenpox in the community. No further information was provided. Additional information is not expected.
administered Bexsero to a 52 year old patient; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 52-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA77AA, expiry date 31st October 2021) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 7th May 2021, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 7th May 2021, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional information was provided as follows: The patient received a dose of Bexsero at an age of 52 years old which led to inappropriate age at vaccine administration. The reporter did not consent to follow up.
pt recv vax 14JUN96 & pt came back to the clinic w/redness, swelling lt deltoid to lt elbow;warm compresses applied;
Patient requested booster dose of moderna shot (0.25 ml) and was given a dose of 0.5 ml
Extreme fatigue developed at approx 1PM  on  09/19/2023   about 24 hours  after the  injection   continued  until  bedtime,  disappeared by morning   09/20/2023..  Fatigue was so severe,  I had  to stay on the  couch... Reddened  area  at  site of  injection,  which enlarged somewhat  on the following  days..and  with increased soreness  on the following days...
Headache, Myalgia, Arthralgia, NauseaVomiting, Chills, Neck and Low Back Pain, Fatigue, Injection Site Pain Narrative:  Other Relevant History:
has mild symptoms of Covid very mild; Just feels off; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (has mild symptoms of Covid very mild) and FEELING ABNORMAL (Just feels off) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SUSPECTED COVID-19 (has mild symptoms of Covid very mild) and FEELING ABNORMAL (Just feels off). At the time of the report, SUSPECTED COVID-19 (has mild symptoms of Covid very mild) and FEELING ABNORMAL (Just feels off) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No information on concomitant medication were reported. No treatment details were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Most recent FOLLOW-UP information incorporated above includes: On 03-Sep-2021: No additional information reported in the follow up.
Patient experienced tingling of the tongue with a metallic taste in her mouth that began about 15 minutes after getting the vaccine.
Patient said he had swollen testicles for two days. It started the morning after his first dose.
3 hrs p/inject pt exp faituge & generalized muscle ache which progressed to angioedema of lips & scrotum, urinary frequency, painful urination; site very painful;